| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/05/2010 | US7807167 using an agent that specifically binds to an alpha-4 integrin or a dimer comprising an alpha-4 integrin; treatment of multiple sclerosis or inflammatory disease of the gastrointestinal tract |
| 10/05/2010 | US7807151 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria |
| 10/05/2010 | US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors |
| 10/05/2010 | CA2370784C Endodontic fibers and methods of use therefor |
| 10/05/2010 | CA2367138C Anti-inflammatory uses of manzamines |
| 09/30/2010 | WO2010110479A1 Activator for peroxisome proliferator-activated receptor |
| 09/30/2010 | WO2010110440A1 Novel therapeutic agent for cognitive impairment |
| 09/30/2010 | WO2010110439A1 Composition for regulating autonomic nervous activity and method for regulating autonomic nerve |
| 09/30/2010 | WO2010110378A1 Pyrazole compound |
| 09/30/2010 | WO2010110026A1 Pharmaceutical composition for metabolic syndrome, obesity, hyperglycemia, hyperlipemia and/or fatty liver |
| 09/30/2010 | WO2010109961A1 Burdock fruit extract containing arctigenin at high content and process for producing same |
| 09/30/2010 | WO2010109093A1 Water soluble defructosylated pea extract, and use thereof as a prebiotic agent |
| 09/30/2010 | WO2010108494A1 Dayspepsia treatment with alginate |
| 09/30/2010 | WO2010108262A1 TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC β-CELL DYSFUNCTION |
| 09/30/2010 | WO2010089510A3 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof |
| 09/30/2010 | WO2010081126A3 Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
| 09/30/2010 | US20100249218 Method to inhibit cell growth using oligonucleotides |
| 09/30/2010 | US20100249203 Compounds that inhibit trpv1 and uses thereof |
| 09/30/2010 | US20100249198 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 09/30/2010 | US20100249192 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/30/2010 | US20100249189 Nitric oxide donor compounds |
| 09/30/2010 | US20100249186 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 09/30/2010 | US20100249183 Therapeutic use of n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives |
| 09/30/2010 | US20100249179 Farnesoid X Receptor Agonists |
| 09/30/2010 | US20100249165 Pdz domain modulators |
| 09/30/2010 | US20100249147 Sulfonyl-substituted 6-membered ring derivative |
| 09/30/2010 | US20100249144 Substituted piperazines as cb1 antagonists |
| 09/30/2010 | US20100249137 Novel sEH Inhibitors and Their Use |
| 09/30/2010 | US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives |
| 09/30/2010 | US20100249118 Compounds and methods for kinase modulation, and indications therefor |
| 09/30/2010 | US20100249098 Oxypiperidine derivatives and methods of use thereof |
| 09/30/2010 | US20100249092 Heteroaryl compounds and uses thereof |
| 09/30/2010 | US20100249084 Substituted pyrimidines as adenosine receptor antagonists |
| 09/30/2010 | US20100249081 Compositions and methods for treatment of renal disease |
| 09/30/2010 | US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 09/30/2010 | US20100249074 Benzyl-cycloalkyl sphingosine 1-phosphate receptor modulators |
| 09/30/2010 | US20100249053 Method for inducing hepatocyte proliferation and uses thereof |
| 09/30/2010 | US20100249034 Gfralpha3 and its uses |
| 09/30/2010 | US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses |
| 09/30/2010 | US20100249023 Isoflavone formulation |
| 09/30/2010 | US20100247658 Organic compounds |
| 09/30/2010 | US20100247652 Alginate Biomaterials for the Treatment of Hepatic Disorders |
| 09/30/2010 | US20100247584 Compositions useful for treating gastroesophageal reflux disease |
| 09/30/2010 | US20100247577 Tr1 cells, mesenchymal stem cells and uses thereof |
| 09/30/2010 | US20100247567 Composition and method for controlling intestinal pathogenic organisms |
| 09/30/2010 | US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function |
| 09/30/2010 | US20100247523 Subtypes of humanized antibody against interleuken-6 receptor |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/30/2010 | US20100247515 Polypeptides, antibody variable domains and antagonists |
| 09/30/2010 | US20100247500 Agent and method for improving survivability of lactic acid bacterium, and food composition |
| 09/30/2010 | US20100247489 Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems |
| 09/30/2010 | US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 09/30/2010 | CA2757067A1 Water soluble defructosylated pea extract, and use thereof as prebiotic agent |
| 09/30/2010 | CA2756801A1 Tissue kallikrein for the treatment of pancreatic .beta.-cell dysfunction |
| 09/30/2010 | CA2756107A1 Composition for regulating autonomic nervous activity and method for regulating autonomic nerve |
| 09/30/2010 | CA2756086A1 Pyrazole compound |
| 09/30/2010 | CA2754416A1 Novel medicament for treating cognitive impairment |
| 09/29/2010 | EP2233575A1 An anti-hcv vaccine and preparation methods and uses thereof |
| 09/29/2010 | EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation. |
| 09/29/2010 | EP2233153A1 Rotavirus vaccine inducing heterotypic cross protection |
| 09/29/2010 | EP2233150A2 Erythropoietin for use in the treatment of wounds or the transplantation of cells |
| 09/29/2010 | EP2233147A1 Salt solution for colon cleansing |
| 09/29/2010 | EP2233146A1 Therapeutic agent for ulcer |
| 09/29/2010 | EP2231707A1 Anti mif antibodies |
| 09/29/2010 | EP2231671A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 09/29/2010 | EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 09/29/2010 | EP2231630A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl]cyclobut anecarboxamide |
| 09/29/2010 | EP2231618A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 09/29/2010 | EP2231589A2 Aminotetralin compounds as mu opioid receptor antagonists |
| 09/29/2010 | EP2231585A2 3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists |
| 09/29/2010 | EP2231174A1 Use larch wood material for treating inflammation |
| 09/29/2010 | EP2230943A1 Paediatric fibre mixture |
| 09/29/2010 | EP1649864B1 Periodontal disease therapeutic and/or preventive composition |
| 09/29/2010 | EP1575670B1 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 09/29/2010 | EP1534695B1 Tyrosine kinase inhibitors |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | CN1985855B Ginkgo health vinegar recipe and preparing method |
| 09/29/2010 | CN1931842B Preparation process of tenatoprazole and its starting compound |
| 09/29/2010 | CN1883634B Preparation process of stomach-caring Chinese medicine with monkey head mushroom |
| 09/29/2010 | CN1868505B 蛇胆粉胶囊 Snake Powder Capsules |
| 09/29/2010 | CN1827634B Nitrate derivatives of glycyrrhetic acid and glycyrrhetinic acid and pharmaceutical use thereof |
| 09/29/2010 | CN1814249B Chinese medicine composition for treating hepatitis and preparation method thereof |
| 09/29/2010 | CN1810777B Compound for preventing and treating bacterial infection and its preparation and use |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101849006A Improved antibody molecule |
| 09/29/2010 | CN101848730A Capsid proteins and uses therefore |
| 09/29/2010 | CN101848713A Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 09/29/2010 | CN101848709A Treatment of oral pharyngeal dysphagia |
| 09/29/2010 | CN101848708A Corticosteroids to treat epothilone or epothilone derivative induced diarrhea |
| 09/29/2010 | CN101845455A Corn expression vector of Hepatitis B virus L gene and application thereof |
| 09/29/2010 | CN101845449A Fusion gene of Hepatitis B virus L gene and tubercle Esat6 and construction and application of expression vector thereof |
| 09/29/2010 | CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/29/2010 | CN101845386A Wild chrysanthemum healthy vinegar and preparation method thereof |
| 09/29/2010 | CN101845383A Earth knee Health care wine |
| 09/29/2010 | CN101845009A Structural carotenoid analogs for the inhibition and amelioration of disease |
| 09/29/2010 | CN101844811A Niobium tungstate compound for resisting hepatitis virus |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843883A Medicinal composition |
| 09/29/2010 | CN101843882A Chinese medicinal composition for treating cholecystitis diseases and preparation method thereof |
| 09/29/2010 | CN101843879A Chinese medicament for treating liver cirrhosis |